SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

China Fund Inc – ‘N-CEN’ for 10/31/18 – ‘INTERNAL CONTROL RPT’

On:  Tuesday, 1/8/19, at 10:33am ET   ·   Effective:  1/8/19   ·   For:  10/31/18   ·   Accession #:  1752724-19-279   ·   File #:  811-05749

Previous ‘N-CEN’:  None   ·   Next:  ‘N-CEN’ on 1/9/20 for 10/31/19   ·   Latest:  ‘N-CEN’ on 1/10/24 for 10/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/08/19  China Fund Inc                    N-CEN      10/31/18    4:71K                                    Confluence Techs Inc/FA

Annual Report by a Registered Investment Company   —   Form N-CEN
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: N-CEN       Annual Report by a Registered Investment Company    HTML     23K 
                          -- primary_doc.xml/1.1                                 
 3: INTERNAL CONTROL RPT  Internal Control Report                      2±    10K 
 2: LEGAL PROCEEDINGS  Legal Proceedings                               2±     8K 
 4: MATERIAL AMENDMENTS  Material Amendment                           17±    70K 


INTERNAL CONTROL RPT   —   Internal Control Report



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and Board of Directors The China Fund, Inc. Boston, Massachusetts In planning and performing our audit of the financial statements of The China Fund, Inc. (the "Fund") as of and for the year ended October 31, 2018, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered its internal control over financial reporting, including control activities for safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Such internal control includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements. Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A control deficiency exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A significant deficiency is a control deficiency, or combination of control deficiencies, that adversely affects the company's ability to initiate, authorize, record, process or report financial data reliably in accordance with accounting principles generally accepted in the United States of America such that there is more than a remote likelihood that a misstatement of the company's annual or interim financial statements that is more than inconsequential will not be prevented or detected. A material weakness is a significant deficiency, or combination of significant deficiencies, that results in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected. To the Shareholders and Board of Directors The China Fund, Inc. Page Two Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be significant deficiencies or material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls for safeguarding securities, which we consider to be material weaknesses, as defined above, as of October 31, 2018. This report is intended solely for the information and use of management, Shareholders and Board of Directors of the Fund and the Securities and Exchange Commission, and is not intended to be and should not be used by anyone other than these specified parties. /s/TAIT, WELLER & BAKER LLP Philadelphia, Pennsylvania December 20, 2018

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘N-CEN’ Filing    Date    Other Filings
Filed on / Effective on:1/8/19
12/20/18
For Period End:10/31/185,  8-K,  N-CSR
 List all Filings 
Top
Filing Submission 0001752724-19-000279   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 7:19:49.1pm ET